| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
NexImmune Inc (NASDAQ: NEXI)
NEXI Technical Analysis
5
| As on 9th Jun 2023 NEXI STOCK Price closed @ 0.32 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.05 & Strong Sell for SHORT-TERM with Stoploss of 3.39 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NEXISTOCK Price
| Open | 0.32 | Change | Price | % |
| High | 0.35 | 1 Day | 0.00 | 0.00 |
| Low | 0.31 | 1 Week | 0.00 | 0.00 |
| Close | 0.32 | 1 Month | -0.05 | -13.51 |
| Volume | 73765 | 1 Year | -4.89 | -93.86 |
| 52 Week High 5.21 | 52 Week Low 0.21 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NEXI Daily Charts |
NEXI Intraday Charts |
Whats New @ Bazaartrend |
NEXI Free Analysis |
|
|
NEXI Important Levels Intraday
| RESISTANCE | 0.40 |
| RESISTANCE | 0.37 |
| RESISTANCE | 0.36 |
| RESISTANCE | 0.34 |
| SUPPORT | 0.30 |
| SUPPORT | 0.28 |
| SUPPORT | 0.27 |
| SUPPORT | 0.24 |
NEXI Forecast May 2024
| 4th UP Forecast | 4.89 |
| 3rd UP Forecast | 3.42 |
| 2nd UP Forecast | 2.52 |
| 1st UP Forecast | 1.61 |
| 1st DOWN Forecast | -0.97 |
| 2nd DOWN Forecast | -1.88 |
| 3rd DOWN Forecast | -2.78 |
| 4th DOWN Forecast | -4.25 |
NEXI Weekly Forecast
| 4th UP Forecast | 2.38 |
| 3rd UP Forecast | 1.72 |
| 2nd UP Forecast | 1.31 |
| 1st UP Forecast | 0.90 |
| 1st DOWN Forecast | -0.26 |
| 2nd DOWN Forecast | -0.67 |
| 3rd DOWN Forecast | -1.08 |
| 4th DOWN Forecast | -1.74 |
NEXI Forecast2024
| 4th UP Forecast | 10.13 |
| 3rd UP Forecast | 6.98 |
| 2nd UP Forecast | 5.04 |
| 1st UP Forecast | 3.09 |
| 1st DOWN Forecast | -2.45 |
| 2nd DOWN Forecast | -4.4 |
| 3rd DOWN Forecast | -6.34 |
| 4th DOWN Forecast | -9.49 |
NexImmune Inc ( NASDAQ USA Symbol : NEXI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NEXI Business Profile
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; and NEXI-002, an autologous cell therapy, which is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland. Address: 9119 Gaither Road, Gaithersburg, MD, United States, 20877
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service